<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04864665</url>
  </required_header>
  <id_info>
    <org_study_id>SBB0E_34098</org_study_id>
    <nct_id>NCT04864665</nct_id>
  </id_info>
  <brief_title>Study to Evaluate the Effects of a Formula on the Gut Health of Healthy Chinese Infants and Young Children</brief_title>
  <official_title>A Prospective, Multicentre Before and After Study to Evaluate the Effects of a Formula With Prebiotics and Milk Fat, on the Gut Health of Chinese Infants and Young Children</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Danone Nutricia</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Nutricia Early Life Nutrition (Shanghai) Co., Ltd</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Danone Nutricia</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The infant gut microbiota, a major driver of the maturation of the immune system, is formed&#xD;
      through the successive establishment and development during infancy and early childhood. It&#xD;
      can inhibit the growth of pathogenic bacteria, prevent the occurrence of diseases and improve&#xD;
      the child's quality of life. It is therefore important to regulate the microbiota balance in&#xD;
      infants and young children.&#xD;
&#xD;
      This objective of this post-launch study is to evaluate the effects of a formula with&#xD;
      prebiotics and milk fat on the gut microbiota and stool characteristics of healthy Chinese&#xD;
      infants and young children. The duration of the study for each participant is 32 days and&#xD;
      includes 3 study visits.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 11, 2021</start_date>
  <completion_date type="Anticipated">May 11, 2022</completion_date>
  <primary_completion_date type="Anticipated">February 7, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>interventional with breastfed reference group</intervention_model_description>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in stool bifidobacteria level</measure>
    <time_frame>32 days</time_frame>
    <description>Stool sample analysis</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in stool lactobacillus level</measure>
    <time_frame>32 days</time_frame>
    <description>Stool sample analysis</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in stool characteristics</measure>
    <time_frame>32 days</time_frame>
    <description>• Stool image analysis based on the 4-point Brussels Infant and Toddler Stool Scale (watery, loose, formed, hard, with hard stools indicating worse outcome)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in gastrointestinal tolerance</measure>
    <time_frame>32 days</time_frame>
    <description>Parent reported questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Satisfaction with the study product</measure>
    <time_frame>32 days</time_frame>
    <description>Parent reported questionnaire</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">495</enrollment>
  <condition>Healthy Children</condition>
  <arm_group>
    <arm_group_label>Formula fed</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>0 - 6 months: a formula with prebiotics and milk fat (Stage 1); &gt;6 - 12 months: a formula with prebiotics and milk fat (Stage 2); &gt;1 - 2 years: a formula with prebiotics and milk fat (Stage 3)</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>a formula with prebiotics and milk fat</intervention_name>
    <description>Provided in a formula added with prebiotics and milk fat for 1 month</description>
    <arm_group_label>Formula fed</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  The gestational age was 37-42 weeks at birth;&#xD;
&#xD;
          -  Birth weight ≥2,500 g and ≤ 4,500 g;&#xD;
&#xD;
          -  Chinese nationality;&#xD;
&#xD;
          -  Weight and height are within normal range (i.e. WHO Child Growth Standards&#xD;
&#xD;
               -  2SD);&#xD;
&#xD;
          -  No relocation across provinces/ cities in the past 1 year and no plans to relocate&#xD;
             during the study period.&#xD;
&#xD;
          -  Breastfeeding reference: breastfeeding at the time of enrollment, and the mother&#xD;
             intends to continue breastfeeding throughout the study period;&#xD;
&#xD;
          -  Intervention arm: formula feeding / habitual milk drinking (formula milk, milk and&#xD;
             other dairy products) at the time of enrollment, and willing to change from the&#xD;
             original milk powder / dairy product to the study formula, and consume it as&#xD;
             instructed during the study period;&#xD;
&#xD;
          -  The child's parent(s) / guardian has access to a mobile phone on which the secure&#xD;
             digital WeChat platform can be installed and used, connect to the network, take&#xD;
             photographs and record defecation, and complete questionnaires during the study;&#xD;
&#xD;
          -  The child's parent(s) / guardian is of legal age of consent, has sufficient command of&#xD;
             Chinese (Mandarin) language to complete the informed consent and other study&#xD;
             documents, is willing and able to fulfill the requirements of the study.&#xD;
&#xD;
          -  The child's parent(s) / guardians can be contacted directly by telephone or WeChat;&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Neonatal asphyxia at birth;&#xD;
&#xD;
          -  Chronic infectious, metabolic, genetic illness or other disease including any&#xD;
             condition that impacts feeding or may impact study outcomes;&#xD;
&#xD;
          -  Cognitive and developmental disorders;&#xD;
&#xD;
          -  Antibiotic usage up to 2 weeks before enrollment;&#xD;
&#xD;
          -  Ongoing antibiotic treatment;&#xD;
&#xD;
          -  Taking probiotic supplements or formula with probiotics up to 1 month before&#xD;
             enrollment;&#xD;
&#xD;
          -  Participation in other clinical trials;&#xD;
&#xD;
          -  Parent(s)' / guardian's refusal to participate in the study;&#xD;
&#xD;
          -  Known or suspected allergy to cow milk, soy or fish&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>2 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Mengjin LIU</last_name>
    <phone>+86-21-61798888</phone>
    <email>register.clinicalresearchnutriciaCN@danone.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Guangdong Province Maternal and Children Hospital</name>
      <address>
        <city>Guangzhou</city>
        <state>Guangdong</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Sitang GONG</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Henan Children's Hospital</name>
      <address>
        <city>Zhengzhou</city>
        <state>Henan</state>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Tangdu Hospital, Air Force Medical University</name>
      <address>
        <city>Xi'an</city>
        <state>Shanxi</state>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Chengdu Women's and Children's Central Hospital</name>
      <address>
        <city>Chengdu</city>
        <state>Sichuan</state>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Ningbo Women and Children's Hospital</name>
      <address>
        <city>Ningbo</city>
        <state>Zhejiang</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Beijing Children's Hospital, Capital Medical University</name>
      <address>
        <city>Beijing</city>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>April 25, 2021</study_first_submitted>
  <study_first_submitted_qc>April 25, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">April 29, 2021</study_first_posted>
  <last_update_submitted>May 17, 2021</last_update_submitted>
  <last_update_submitted_qc>May 17, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 19, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Prebiotics</keyword>
  <keyword>Gut microbiota</keyword>
  <keyword>Formula</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

